CRP and COVID-19: Similar to other studies which investigated efficacy and safety of treating LoP/R in COVID-19 patients, this study also showed that none of patients in CA/LoP group showed serious adverse effects, but only few patients reported an increase in liver enzyme though with no statistical significance and elevated levels of CRP and LDH before matching.